Laura Ann Kresty
John A and Carla S Klein Family
Mark B Orringer Research Professor of Thoracic Surgery
Associate Professor of Surgery
Department of Surgery/Section of Thoracic
6304 Rogel Cancer Center/1500 E Medical Center Drive,
Ann Arbor,, Michigan 48109
[email protected]

Available to mentor
Laura Ann Kresty
Associate Professor
  • Qualifications
  • Center Memberships
  • Recent Publications
    • Qualifications
    • Postdoctoral Research Fellow
      The Ohio State University, Division of Environmental Health Sciences, 2003
    Center Memberships
    • Center Member
      Rogel Cancer Center
    Recent Publications See All Publications
    • Proceeding / Abstract / Poster
      Abstract 550: Identification of isoform switching events linked with esophageal adenocarcinoma patient survival informs novel prognostic and therapeutic targets
      Zhang Y, Israel R, Vandenburg B, Barnett S, Riethoven J-J, Clarke JL, Lee MP, Lagisetty K, Lin J, Reddy R, Chang A, Kresty LA. Cancer Research, 2024 Mar 22; 84 (6_Supplement): 550 - 550. DOI:10.1158/1538-7445.am2024-550
    • Journal Article
      Prebiotic proanthocyanidins inhibit bile reflux-induced esophageal adenocarcinoma through reshaping the gut microbiome and esophageal metabolome.
      Weh KM, Howard CL, Zhang Y, Tripp BA, Clarke JL, Howell AB, Rubenstein JH, Abrams JA, Westerhoff M, Kresty LA. bioRxiv, 2023 Aug 23; DOI:10.1101/2023.08.22.554315
      PMID: 37662411
    • Journal Article
      Cranberry Proanthocyanidins Mitigate Reflux-Induced Transporter Dysregulation in an Esophageal Adenocarcinoma Model.
      Zhang Y, Weh KM, Tripp BA, Clarke JL, Howard CL, Sunilkumar S, Howell AB, Kresty LA. Pharmaceuticals (Basel), 2023 Dec 7; 16 (12): DOI:10.3390/ph16121697
      PMID: 38139823
    • Presentation
      Invited Speaker: “Cranberry Polyphenols Inhibit Esophageal Cancer through Reshaping the Microbiome-Metabolome Axis”
      2023 Sep 28;
    • Presentation
      Invited Speaker: “Isoform switching events may provide new insight for the identification of prognostic and therapeutic targets in esophageal" adenocarcinoma”
      2023 Sep 8;
    • Proceeding / Abstract / Poster
      451. ISOFORM SWITCHING EVENTS MAY PROVIDE NEW INSIGHT FOR THE IDENTIFICATION OF PROGNOSTIC AND THERAPEUTIC TARGETS IN ESOPHAGEAL ADENOCARCINOMA
      Zhang Y, Howard C, Israel R, Vandenburg B, Barnett S, Riethoven J-J, Clarke J, Lagisetty K, Lin J, Reddy R, Chang A, Kresty LA. Diseases of the Esophagus, 2023 Aug 30; 36 (Supplement_2): doad052.239 DOI:10.1093/dote/doad052.239
    • Preprint
      Prebiotic proanthocyanidins inhibit bile reflux-induced esophageal adenocarcinoma through reshaping the gut microbiome and esophageal metabolome
      Weh KM, Howard CL, Zhang Y, Tripp BA, Clarke JL, Howell AB, Rubenstein JH, Abrams JA, Westerhoff M, Kresty LA. bioRxiv, DOI:10.1101/2023.08.22.554315
    • Presentation
      Invited Speaker: “Prebiotic Proanthocyanidins Inhibit Bile Reflux-induced Esophageal Adenocarcinoma through Reshaping the Microbiome-metabolome Axis” III
      2023 Jul 13;